At this difficult time we all want to know how best to treat our patients. For this reason BTOG believes that for COVID-19 infected patients with thoracic malignancies, data capture at the International level is paramount.
BTOG therefore strongly supports the TERAVOLT consortium, which is an International registry of such COVID-19 infected patients with thoracic malignancies with outcomes. It can be set up as a service evaluation/audit with local approvals, only.
Wishing you and your family all good heath.
Professor Sanjay Popat,
BTOG Steering Committee Chair